Drug class in one race

Thyroid hormone receptor-beta drugs for Metabolic Dysfunction-Associated Steatohepatitis

2 tracked Thyroid hormone receptor-beta drugs in the Metabolic Dysfunction-Associated Steatohepatitis race. The class explanation lives on the Thyroid hormone receptor-beta page; the full indication pipeline across every mechanism is on the Metabolic Dysfunction-Associated Steatohepatitis page.

1 approved / phase 41 preclinical / unstaged

The roster

← all Thyroid hormone receptor-beta drugs